S182: TALQUETAMAB, A G PROTEIN-COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM MONUMENTAL-1

• M. C. Minnema,
• A. Krishnan,
• J. G. Berdeja,
• A. Oriol,
• N. W. van de Donk,
• P. Rodríguez-Otero,
• D. Morillo,
• M.-V. Mateos,
• L. J. Costa,
• J. Caers,
• D. Vishwamitra,
• J. Ma,
• S. Yang,
• B. W. Hilder,
• J. Tolbert,
• J. D. Goldberg,
• A. Chari

Affiliations

M. C. Minnema

1 University Medical Center Utrecht, Utrecht, Netherlands

A. Krishnan

2 City of Hope Comprehensive Cancer Center, Duarte, CA

J. G. Berdeja

3 Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, United States of America

A. Oriol

4 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain

N. W. van de Donk

5 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

P. Rodríguez-Otero

6 Clínica Universidad de Navarra, Navarra

D. Morillo

7 Hospital Universitario Fundación Jiménez Díaz, Madrid

M.-V. Mateos

8 University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

L. J. Costa

9 University of Alabama at Birmingham, Birmingham, AL, United States of America

J. Caers

10 University of Liège, Liège, Belgium

D. Vishwamitra

11 Janssen Research & Development, Spring House, PA

J. Ma

11 Janssen Research & Development, Spring House, PA

S. Yang

11 Janssen Research & Development, Spring House, PA

B. W. Hilder

11 Janssen Research & Development, Spring House, PA

J. Tolbert

11 Janssen Research & Development, Spring House, PA

J. D. Goldberg

12 Janssen Research & Development, Raritan, NJ

A. Chari

13 Mount Sinai School of Medicine, New York, NY, United States of America